Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03109262 · ClinicalTrials.gov registry record · NA
Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT03109262: Completed NA study, sponsored by Stanford University.
NCT03109262 is a NA study that has completed, run by Stanford University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03109262, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This clinical trial studies how well yttrium-90 (Y90) glass microspheres positron emission tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors . Images produced by PET/CT may provide better information about the distribution of particles, such as Y90 glass microspheres, delivered for selective internal radiation therapy (SIRT) as compared to regular medical care images useing technetium Tc-99m albumin-aggregated single photon emission computed tomography (SPECT)/CT images.
Interventions
- PROCEDURE Computed Tomography (CT)
- PROCEDURE Positron Emission Tomography (PET)
- DEVICE 90-Yttrium (Y-90) Glass Microspheres
- DIAGNOSTIC_TEST Technetium 99mTc albumin aggregated (99mTc-MAA)
- PROCEDURE Single-photon emission computerized tomography (SPECT) scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03109262
The ClinicalTrials.gov registry entry for NCT03109262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Computed Tomography (CT) is the first listed.
NCT03109262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03109262 about?
NCT03109262 is a clinical study titled "Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors". This clinical trial studies how well yttrium-90 (Y90) glass microspheres positron emission tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors . Images produced by PET/CT may provide better information about the distribution of particles, such as Y90 glass microsphe...
What is the current status of trial NCT03109262?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2017-02-15. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT03109262?
The interventions under investigation include: Computed Tomography (CT) (PROCEDURE), Positron Emission Tomography (PET) (PROCEDURE), 90-Yttrium (Y-90) Glass Microspheres (DEVICE), Technetium 99mTc albumin aggregated (99mTc-MAA) (DIAGNOSTIC_TEST), Single-photon emission computerized tomography (SPECT) scan (PROCEDURE).
Who is sponsoring clinical trial NCT03109262?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.